Here’s what you should know:
1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.
2. Motus was attempting to offer 4.3 million shares initially, but reduced the scope of the offer ahead of the pricing. Motus is now selling 3.5 million shares. Motus had a price range between $5 and $7 per share in the IPO.
3. Motus is trading under the symbol MOTS.
More articles on supply chain:
Maine physician: Halting physician-aimed opioid marketing now is ’20 years’ too late
Somnia Anesthesia shakes up leadership team with new appointments — 3 insights
Survey says medical students learn the most about perioperative medicine by pairing anesthesiology with general surgery rotation
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
